Cargando…

A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect

One year following bladder cancer surgery, a 65‐year‐old man had computed tomography (CT) that revealed bilateral pulmonary nodules. Pulmonary wedge resections were performed after the nodules were found to grow in follow‐up. Unusually, we found that these two lesions were not homologous, nor were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yuling, Wang, Xuedi, Fan, Yingrui, Bao, Yanru, Meng, Fanqing, Liu, Baorui, Li, Rutian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175027/
https://www.ncbi.nlm.nih.gov/pubmed/36965139
http://dx.doi.org/10.1111/1759-7714.14864
_version_ 1785040160601145344
author Qiu, Yuling
Wang, Xuedi
Fan, Yingrui
Bao, Yanru
Meng, Fanqing
Liu, Baorui
Li, Rutian
author_facet Qiu, Yuling
Wang, Xuedi
Fan, Yingrui
Bao, Yanru
Meng, Fanqing
Liu, Baorui
Li, Rutian
author_sort Qiu, Yuling
collection PubMed
description One year following bladder cancer surgery, a 65‐year‐old man had computed tomography (CT) that revealed bilateral pulmonary nodules. Pulmonary wedge resections were performed after the nodules were found to grow in follow‐up. Unusually, we found that these two lesions were not homologous, nor were they metastases from prior bladder cancer, and therefore, synchronous double primary lung cancer (sDPLC) was diagnosed. The immunohistochemical findings excluded the possibility of bladder cancer metastasis, but could not determine whether they were from the same source. Next generation sequencing (NGS) supported the diagnosis sDPLC because they amply demonstrated the two sources’ distinct origins. Finally, after discussion with pathologists, this patient was diagnosed as small cell lung carcinoma (SCLC) and received postoperative EP chemotherapy. We also documented a few rather uncommon alterations that might serve as a foundation for further investigation. This case suggests that in addition to immunohistochemical, NGS is also helpful to clarify the etiology and refine the pathological classification of tumors, which has guiding significance for the establishment of precise diagnosis and optimal treatment.
format Online
Article
Text
id pubmed-10175027
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-101750272023-05-12 A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect Qiu, Yuling Wang, Xuedi Fan, Yingrui Bao, Yanru Meng, Fanqing Liu, Baorui Li, Rutian Thorac Cancer Case Reports One year following bladder cancer surgery, a 65‐year‐old man had computed tomography (CT) that revealed bilateral pulmonary nodules. Pulmonary wedge resections were performed after the nodules were found to grow in follow‐up. Unusually, we found that these two lesions were not homologous, nor were they metastases from prior bladder cancer, and therefore, synchronous double primary lung cancer (sDPLC) was diagnosed. The immunohistochemical findings excluded the possibility of bladder cancer metastasis, but could not determine whether they were from the same source. Next generation sequencing (NGS) supported the diagnosis sDPLC because they amply demonstrated the two sources’ distinct origins. Finally, after discussion with pathologists, this patient was diagnosed as small cell lung carcinoma (SCLC) and received postoperative EP chemotherapy. We also documented a few rather uncommon alterations that might serve as a foundation for further investigation. This case suggests that in addition to immunohistochemical, NGS is also helpful to clarify the etiology and refine the pathological classification of tumors, which has guiding significance for the establishment of precise diagnosis and optimal treatment. John Wiley & Sons Australia, Ltd 2023-03-25 /pmc/articles/PMC10175027/ /pubmed/36965139 http://dx.doi.org/10.1111/1759-7714.14864 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Qiu, Yuling
Wang, Xuedi
Fan, Yingrui
Bao, Yanru
Meng, Fanqing
Liu, Baorui
Li, Rutian
A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect
title A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect
title_full A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect
title_fullStr A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect
title_full_unstemmed A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect
title_short A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect
title_sort case of bilateral synchronous double primary lung cancer secondary to bladder cancer: from the next‐generation sequencing prospect
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175027/
https://www.ncbi.nlm.nih.gov/pubmed/36965139
http://dx.doi.org/10.1111/1759-7714.14864
work_keys_str_mv AT qiuyuling acaseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT wangxuedi acaseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT fanyingrui acaseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT baoyanru acaseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT mengfanqing acaseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT liubaorui acaseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT lirutian acaseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT qiuyuling caseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT wangxuedi caseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT fanyingrui caseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT baoyanru caseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT mengfanqing caseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT liubaorui caseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect
AT lirutian caseofbilateralsynchronousdoubleprimarylungcancersecondarytobladdercancerfromthenextgenerationsequencingprospect